Rachel Klemovitch, Assistant Editor06.26.24
A new study found that ZetrOZ Systems’ sustained acoustic medicine (sam) and other low-intensity continuous ultrasound technology, alleviated the symptoms of chronic lower back pain and reduced the need for pain medication.
The study examined the effect of low-intensity continuous ultrasound on chronic low back pain and how it can alleviate symptoms of chronic low back pain (CLBP) during a randomized, double-blind, placebo-controlled trial.
The study included 65 patients (26 men, 39 women, average age of 47) who suffered from CBLP for over three months. They were assigned to a LICUS or placebo treatment with baseline pain levels and medication usage recorded over two weeks before treatment.
Participants underwent four-hour lower lumbar region treatments daily, with either active or placebo treatment for eight weeks. They maintained daily diaries and reported biweekly pain levels on the numeric rating scale, global rating of change, medication reduction, physical activity, and functionality.
![](https://images.rodpub.com/images/309/072_main.jpg)
The researchers concluded: “Daily LICUS treatment significantly alleviates clinical symptoms of CLBP relative to placebo treatment. LICUS is a safe and non-invasive therapeutic option for patients with CLBP.”
Overall, there was a significant reduction in pain levels, which was substantial in the first two weeks and gradually decreased over the following six weeks.
“We’re pleased to see another study affirming how our sam wearable ultrasound unit accelerates tissue healing and relieves pain, especially for people who suffer from low back pain,” said George K. Lewis, Ph.D., founder and CEO of ZetrOZ Systems. “Our sam devices have a proven track record of treating soft tissue injury successfully and helping people feel less pain and be more active.”